Atlas Trials

Marinus Pharmaceuticals

22 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Marinus Pharmaceuticals

RecordFirmDate
To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE) (NCT05814523)Marinus Pharmaceuticals2024-03-01
Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE) (NCT05757544)Marinus Pharmaceuticals2023-04-01
Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy (NCT05604170)Marinus Pharmaceuticals2022-05-16
Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy (NCT05323734)Marinus Pharmaceuticals2022-04-01
Randomized Therapy In Status Epilepticus (NCT04391569)Marinus Pharmaceuticals2020-12-09
Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B) (NCT04285346)Marinus Pharmaceuticals2020-04-08
Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study) (NCT03865732)Marinus Pharmaceuticals2019-05-17
Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder (NCT03572933)Marinus Pharmaceuticals2018-06-30
A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression (NCT03460756)Marinus Pharmaceuticals2017-12-28

Track Marinus Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.